Background illustration for clinical trials search

Paid Clinical Trials St. Petersburg

Discover 1,443 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,443

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for

Cardiovascular Disease

Location: Largo FL, Seminole FL, Clearwater FL, Tampa FL,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for

Acute Coronary Syndrome

Location: Largo FL, Clearwater FL, Tampa FL, Safety Harbor FL,

Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for

Generalized Myasthenia Gravis

Location: Clearwater FL, Tampa FL, Port Charlotte FL,

Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase3, Recruiting

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

for

Heart Failure

Location: Largo FL, Clearwater FL, Brandon FL, Tampa FL,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06424288

Phase3, Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for

High-Risk Non-Muscle-Invasive Bladder Cancer

Location: Largo FL, Oxford FL, Gainesville FL, Jacksonville FL,

Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase2, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Location: Largo FL, Sarasota FL, Jacksonville FL, Mobile AL,

Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase3, Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

for

Non-Muscle Invasive Bladder Neoplasms

Location: Largo FL, Atlanta GA, Myrtle Beach SC, Lafayette LA,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06919965

Phase3, Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for

Metastatic Castration Sensitive Prostate Cancer (mCSPC),

Location: Largo FL, Myrtle Beach SC, Dalton GA, Ringgold GA,

Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT07028853

Phase3, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Location: Largo FL, Riverview FL, Ocala FL, Daytona Beach FL,

Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase2, Recruiting

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

for

Major Depressive Disorder

Location: Tampa FL, Brandon FL, Jacksonville FL, Miami Gardens FL,

Sponsor: Autobahn Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06633016

Phase2, Recruiting

Study of ALTO-300 in MDD

for

Major Depressive Disorder

Location: Tampa FL, Clermont FL, Okeechobee FL,

Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT05922878

Phase2, Recruiting

Lay-Delivered Behavioral Activation in Senior Centers

for

Depression

Location: Ruskin FL, Tampa FL, Gibsonton FL, Brandon FL,

Sponsor: University of Washington

Sex: All

Age: 60+

Code: NCT04621877

Recruiting

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

for

Major Depressive Disorder

Location: Tampa FL, Miami FL, Decatur GA, Atlanta GA,

Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18 - 65

Code: NCT05850689

Phase3, Recruiting

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

for

Depressive Disorder, Major

Location: Tampa FL, West Palm Beach FL, Doral FL, Hialeah FL,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07573176

Phase3, Recruiting

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

for

Alzheimer Disease, Agitation

Location: Tampa FL, Port Orange FL, Virginia Gardens FL, Miami FL,

Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT06937229

Phase3, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

for

Alzheimer's Disease

Location: Tampa FL, Bradenton FL, Bonita Springs FL, Miami FL,

Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011745

Phase3, Recruiting

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

for

Psychosis Associated With Alzheimer's Disease

Location: Tampa FL, Clermont FL, Orlando FL, Maitland FL,

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT05980949

Phase3, Recruiting

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

for

Depressive Disorder, Major

Location: Tampa FL, Brandon FL, Orlando FL, West Palm Beach FL,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT06559306

Phase3, Recruiting

A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Presbyopic Subjects

for

Presbyopia, Pseudophakia

Location: Largo FL, Bradenton FL, Houston TX, Bowie MD, Dallas TX,

Sponsor: ReVision Optics, Inc.

Sex: All

Age: 50+

Code: NCT02668523

Phase3, Recruiting

DSLT for Reducing Medication in Glaucoma

for

Primary Open Angle Glaucoma, Ocular Hypertension

Location: Largo FL

Sponsor: The Eye Institute of West Florida

Sex: All

Age: 0+

Code: NCT07390890

Recruiting

Paid Clinical Trials St. Petersburg

Filter results

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Interested in new trials?

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Study of ALTO-300 in MDD

Lay-Delivered Behavioral Activation in Senior Centers

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Presbyopic Subjects

DSLT for Reducing Medication in Glaucoma